Name
meanrt
Label
Psychomotor Vigilance Test (PVT) Mean RT (msec)
Description
PVT QC Rules 3-25-09 FINAL
Type
numeric
Visit (Number) vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
Clinical Evaluation (CE) | - | - | - | - | - | - | 1,516 | 1,516 |
Diagnostic Visit (DX) | 1,199 | 272.8 | ± 79.1 | 260.8 | -888.0 | 978.5 | 317 | 1,516 |
CPAP Titration Visit (CPAP) | - | - | - | - | - | - | 1,516 | 1,516 |
Two Month Post-CPAP Neurocognitive Visit (2M) | 877 | 269.9 | ± 68.0 | 261.5 | -888.0 | 935.0 | 639 | 1,516 |
Four Month Post-CPAP Neurocognitive Visit (4M) | - | - | - | - | - | - | 1,516 | 1,516 |
Six Month Post-CPAP Neurocognitive Visit (6M) | 848 | 269.9 | ± 68.0 | 260.2 | -888.0 | 911.0 | 668 | 1,516 |
Gender vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,199 | 272.8 | ± 79.1 | 260.8 | -888.0 | 978.5 | 317 | 1,516 |
Male | 767 | 265.1 | ± 70.8 | 255.4 | -888.0 | 930.7 | 191 | 958 |
Female | 432 | 286.4 | ± 90.5 | 272.8 | -888.0 | 978.5 | 126 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 877 | 269.9 | ± 68.0 | 261.5 | -888.0 | 935.0 | 639 | 1,516 |
Male | 569 | 264.3 | ± 50.9 | 256.5 | 180.1 | 892.6 | 389 | 958 |
Female | 308 | 280.4 | ± 90.8 | 270.4 | -888.0 | 935.0 | 250 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 848 | 269.9 | ± 68.0 | 260.2 | -888.0 | 911.0 | 668 | 1,516 |
Male | 550 | 264.7 | ± 50.2 | 256.4 | 172.5 | 788.2 | 408 | 958 |
Female | 298 | 279.5 | ± 91.5 | 269.7 | -888.0 | 911.0 | 260 | 558 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,199 | 272.8 | ± 79.1 | 260.8 | -888.0 | 978.5 | 317 | 1,516 |
Native American | 20 | 290.8 | ± 115.6 | 266.2 | 215.7 | 759.6 | 8 | 28 |
Asian | 71 | 271.9 | ± 79.7 | 255.6 | 203.1 | 822.5 | 18 | 89 |
Black | 115 | 279.8 | ± 59.9 | 266.6 | 170.9 | 600.4 | 57 | 172 |
Hispanic | 83 | 278.3 | ± 81.3 | 258.8 | 217.9 | 876.8 | 33 | 116 |
White | 902 | 270.9 | ± 80.0 | 260.9 | -888.0 | 978.5 | 200 | 1,102 |
Other | 8 | 290.4 | ± 93.2 | 257.4 | 214.2 | 508.1 | 1 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 877 | 269.9 | ± 68.0 | 261.5 | -888.0 | 935.0 | 639 | 1,516 |
Native American | 13 | 289.2 | ± 43.7 | 283.6 | 227.8 | 399.5 | 15 | 28 |
Asian | 48 | 262.7 | ± 42.8 | 254.2 | 198.4 | 453.5 | 41 | 89 |
Black | 76 | 250.6 | ± 138.7 | 257.7 | -888.0 | 416.4 | 96 | 172 |
Hispanic | 65 | 289.5 | ± 104.2 | 267.4 | 205.5 | 935.0 | 51 | 116 |
White | 672 | 270.3 | ± 51.0 | 261.7 | 196.7 | 892.6 | 430 | 1,102 |
Other | 3 | 295.1 | ± 25.2 | 285.9 | 275.9 | 323.6 | 6 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Mean RT (msec)
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 848 | 269.9 | ± 68.0 | 260.2 | -888.0 | 911.0 | 668 | 1,516 |
Native American | 13 | 281.3 | ± 45.3 | 265.9 | 226.8 | 399.3 | 15 | 28 |
Asian | 50 | 264.5 | ± 42.4 | 254.0 | 215.5 | 423.5 | 39 | 89 |
Black | 75 | 278.0 | ± 74.2 | 266.9 | 172.5 | 788.2 | 97 | 172 |
Hispanic | 61 | 284.5 | ± 93.5 | 263.0 | 211.9 | 911.0 | 55 | 116 |
White | 646 | 267.8 | ± 66.4 | 259.6 | -888.0 | 707.4 | 456 | 1,102 |
Other | 3 | 276.9 | ± 15.9 | 268.2 | 267.2 | 295.3 | 6 | 9 |